Text Size
72 studies found for:    Open Studies | "Dermatitis, Atopic"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Not yet recruiting Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.
Condition: Atopic Dermatitis
Interventions: Drug: QAW039;   Drug: Placebo
22 Unknown † Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Condition: Atopic Dermatitis
Intervention: Drug: tacrolimus ointment
23 Not yet recruiting A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: CT327 ointment;   Drug: placebo
24 Recruiting A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: OPA-15406;   Drug: Tacrolimus;   Drug: Placebo
25 Recruiting An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: PDI-192;   Drug: Vehicle
26 Recruiting Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Condition: Moderate/Severe Atopic Dermatitis
Intervention: Drug: tacrolimus
27 Recruiting Emollients in the Management of Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: glycerol, paraffin (liquid and white soft);   Device: Atopiclair®;   Drug: Locatop@;   Drug: Locapred@
28 Recruiting Pediatric Atopic Dermatitis (AD) Internet Survey
Condition: Atopic Dermatitis
Interventions: Behavioral: Weekly Internet survey;   Drug: Topical Triamcinolone
29 Recruiting KM110329 in Adult Patients With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Dietary Supplement: KM110329;   Dietary Supplement: Placebo
30 Recruiting Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: Fluocinonide cream
31 Recruiting Study of Dupilumab (REGN668/ SAR231893) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Dupilumab (REGN668/ SAR231893);   Drug: Placebo
32 Recruiting Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
Condition: Atopic Dermatitis
Intervention: Drug: Extended release tacrolimus (Advagraf®)
33 Recruiting Topical Roflumilast in Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Roflumilast;   Drug: Roflumilast placebo
34 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Conditions: Atopic Dermatitis;   Netheron's Syndrome;   Piebaldism;   Hyper IgE Syndrome;   Ichthyosis;   Anaphylaxis;   Severe Allergy
Intervention:
35 Recruiting A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
Condition: Atopic Dermatitis
Interventions: Drug: MK-8226;   Drug: Placebo
36 Unknown † Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
Condition: Moderate to Severe Atopic Dermatitis
Interventions: Other: Dilute bleach baths;   Other: Water
37 Recruiting Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Condition: Mild to Moderate Atopic Dermatitis
Intervention: Drug: HL-009 Liposomal Gel
38 Recruiting A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis
Condition: Healthy Subjects and Atopic Dermatitis Subjects
Interventions: Biological: BMS-981164;   Biological: Placebo matching with BMS-981164
39 Recruiting Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Conditions: Atopic Dermatitis;   Eczema;   Ichthyosis Vulgaris
Intervention:
40 Recruiting Evaluate Reversal of Pathological Epidermal Phenotype in Severe Atopic Dermatitis (AD) With Suppression of Immune Activation During Cyclosporine A Therapy
Conditions: Atopic Dermatitis;   Eczema
Intervention: Drug: Cyclosporine A
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years